CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a wholesale distribution agreement with a U.S.-based manufacturer of cannabidiol-based products. Through this agreement, CDII will purchase cannabidiol (CBD) products at a wholesale price before marketing them to the Chinese-speaking population.
“We are very excited to bring these premium CBD-based products, manufactured in the U.S., to the Chinese-speaking population,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “As CBD-based products are new in the Chinese market, we believe it is an ideal point in time to bring top-quality product lines to the Chinese market place. We are prepared to be the pioneer that can empower the health conscious Chinese population with top quality premium CBD-based supplements.”
CDII’s new distribution partner currently markets a wide assortment of popular CBD-based products and supplements. Some of the most popular include Chill and Relax Gummies, a tasty selection of more than 200 flavored CBD hemp oils, Blue CBD Crystals Isolate, the Relax Extreme CBD collection, CBD shots and premium vape additives.
This morning’s update comes just a week after CDII announced its entry into a partnership agent sales agreement with NutraFuels, Inc. (OTC: NTFU), a manufacturer, marketer and distributor of naturally-derived liquid-based health and wellness nutraceutical products. Through that partnership, the company gained access to five of NutraFuels’ oral spray daily health and wellness products, which it also intends to market to the Chinese-speaking population. With a global community including more than two billion people, the Chinese-speaking population represents a sizable opportunity for CDII as the CBD market continues to gain steam both in China and around the world.
Data published by The Hemp Business Journal notes that CBD and related products represent one the fastest-growing market categories in the hemp and legal marijuana industries, achieving a compound annual growth rate of 59 percent in the U.S. In 2015, the CBD industry was valued at roughly $202 million, and it is expected to grow to $2.1 billion in consumer sales by 2020. With this performance in mind, CDII is actively sourcing a variety of CBD-based products in the U.S., with plans to enter into additional distribution agreements in the near term. The company intends to distribute these products through both its newly-launched online store (http://www.greencbdproducts.com/cbd) and retail chains of pharmaceutical and Chinese medicine stores in Mainland China.
For more information, visit the company’s website at www.CDII.net
Let us hear your thoughts: CD International Enterprises, Inc. Message Board